^SAMPLE = GSM3722301
!Sample_title = ATAC-seq_ETV4KO1_DMSO
!Sample_geo_accession = GSM3722301
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = treatment: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417699
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683087
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722301/suppl/GSM3722301_ETV4KO1_DMSO_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722302
!Sample_title = ATAC-seq_ETV4KO1_1hrE2
!Sample_geo_accession = GSM3722302
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = treatment: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417704
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683088
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722302/suppl/GSM3722302_ETV4KO1_1hrE2_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722303
!Sample_title = ATAC-seq_ETV4KO2_DMSO
!Sample_geo_accession = GSM3722303
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = treatment: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417703
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683089
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722303/suppl/GSM3722303_ETV4KO2_DMSO_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722304
!Sample_title = ATAC-seq_ETV4KO2_1hrE2
!Sample_geo_accession = GSM3722304
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = treatment: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417702
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683090
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722304/suppl/GSM3722304_ETV4KO2_1hrE2_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722305
!Sample_title = ATAC-seq_WTIshikawa_DMSO
!Sample_geo_accession = GSM3722305
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = treatment: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417701
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683091
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722305/suppl/GSM3722305_WTIshikawa_DMSO_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722306
!Sample_title = ATAC-seq_WTIshikawa_1hrE2
!Sample_geo_accession = GSM3722306
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = treatment: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = 250,000 cells were collected and ATAC assay was performed as described in Buenrostro, et al. 2013.
!Sample_extract_protocol_ch1 = Library was constructed as described in Buenrostro, et al. 2013.
!Sample_data_processing = Sequencing reads were aligned by Bowtie to the hg19 build of the human genome using the following parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Read counts were calculated using featureCounts from the SubRead package
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = other
!Sample_library_source = genomic
!Sample_library_strategy = ATAC-seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417700
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683092
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722306/suppl/GSM3722306_WTIshikawa_1hrE2_ATAC.bedgraph.gz
!Sample_series_id = GSE129802
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722307
!Sample_title = ChIP-seq_Ishi_E21hr_ER
!Sample_geo_accession = GSM3722307
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417698
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683074
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722307/suppl/GSM3722307_WTIshikawa_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722307/suppl/GSM3722307_WTIshikawa_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722308
!Sample_title = ChIP-seq_Ishi_ETV4KO1_E21hr_ER
!Sample_geo_accession = GSM3722308
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417697
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683075
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722308/suppl/GSM3722308_ETV4KO1_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722308/suppl/GSM3722308_ETV4KO1_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722309
!Sample_title = ChIP-seq_Ishi_ETV4KO2_E21hr_ER
!Sample_geo_accession = GSM3722309
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417696
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683076
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722309/suppl/GSM3722309_ETV4KO2_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722309/suppl/GSM3722309_ETV4KO2_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722310
!Sample_title = ChIP-seq_Ishi_Ishi_DMSO_Input
!Sample_geo_accession = GSM3722310
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = genotype: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417695
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683077
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722311
!Sample_title = ChIP-seq_Ishi_Ishi_E21hr_ER_B
!Sample_geo_accession = GSM3722311
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417694
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683078
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722311/suppl/GSM3722311_WTIshikawa_ER_E2_B.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722311/suppl/GSM3722311_WTIshikawa_ER_E2_B.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722312
!Sample_title = ChIP-seq_Ishi_ETV4KO1_E21hr_ER_B
!Sample_geo_accession = GSM3722312
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417693
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683079
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722312/suppl/GSM3722312_ETV4KO1_ER_E2_B.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722312/suppl/GSM3722312_ETV4KO1_ER_E2_B.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722313
!Sample_title = ChIP-seq_Ishi_ETV4KO2_E21hr_ER_B
!Sample_geo_accession = GSM3722313
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417692
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683080
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722313/suppl/GSM3722313_ETV4KO2_ER_E2_B.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722313/suppl/GSM3722313_ETV4KO2_ER_E2_B.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722314
!Sample_title = ChIP-seq_Ishi_WT_ETV4Overexpression_ER_E2
!Sample_geo_accession = GSM3722314
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 ectopic expression
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 ectopic expression
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417691
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683081
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722314/suppl/GSM3722314_WT_ETV4Overexpression_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722314/suppl/GSM3722314_WT_ETV4Overexpression_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722315
!Sample_title = ChIP-seq_Ishi_ETV4KO1_Rescue_ER_E2
!Sample_geo_accession = GSM3722315
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone1, ETV4 ectopic expression
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO, ETV4 ectopic expression
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417690
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683082
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722315/suppl/GSM3722315_ETV4KO1_Rescue_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722315/suppl/GSM3722315_ETV4KO1_Rescue_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722316
!Sample_title = ChIP-seq_Ishi_ETV4KO2_Rescue_ER_E2
!Sample_geo_accession = GSM3722316
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2, ETV4 ectopic expression
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 KO, ETV4 ectopic expression
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417689
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683083
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722316/suppl/GSM3722316_ETV4KO2_Rescue_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722316/suppl/GSM3722316_ETV4KO2_Rescue_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722317
!Sample_title = ChIP-seq_Ishi_T47D_ER_E2
!Sample_geo_accession = GSM3722317
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: T-47D ETV4 ectopic expression
!Sample_characteristics_ch1 = cell type: ER+ breast ductal carcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_characteristics_ch1 = genotype: ETV4 ectopic expression
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417688
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683084
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722317/suppl/GSM3722317_T47D_ER_E2.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722317/suppl/GSM3722317_T47D_ER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722318
!Sample_title = ChIP-seq_Ishi_T47D_ETV4_FLAG
!Sample_geo_accession = GSM3722318
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 25 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = FLAG-ETV4 ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: T-47D ETV4 ectopic expression
!Sample_characteristics_ch1 = cell type: ER+ breast ductal carcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Sigma FLAG M2
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = genotype: ETV4 ectopic expression
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = FLAG-ETV4 ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417687
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683085
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722318/suppl/GSM3722318_T47D_FLAG_ETV4.bedgraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3722nnn/GSM3722318/suppl/GSM3722318_T47D_FLAG_ETV4.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722319
!Sample_title = ChIP-seq_Ishi_T47D_DMSO_Input
!Sample_geo_accession = GSM3722319
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = ER ChIP-seq
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: T-47D
!Sample_characteristics_ch1 = cell type: ER+ breast ductal carcinoma cell line
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_characteristics_ch1 = genotype: WT
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 1 hour
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) and T-47D cells (ATCC) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417686
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683086
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722320
!Sample_title = RNA-seq_ETV4KO1_DMSO
!Sample_geo_accession = GSM3722320
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = May 06 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683060
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417647
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722321
!Sample_title = RNA-seq_ETV4KO1_E2
!Sample_geo_accession = GSM3722321
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417652
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683061
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722322
!Sample_title = RNA-seq_ETV4KO2_DMSO
!Sample_geo_accession = GSM3722322
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417651
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683062
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722323
!Sample_title = RNA-seq_ETV4KO2_E2
!Sample_geo_accession = GSM3722323
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417650
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683063
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722324
!Sample_title = RNA-seq_WTIshikawa_DMSO
!Sample_geo_accession = GSM3722324
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 0.1% DMSO
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 0.1% DMSO
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417649
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683064
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM3722325
!Sample_title = RNA-seq_WTIshikawa_E2
!Sample_geo_accession = GSM3722325
!Sample_status = Public on Apr 23 2019
!Sample_submission_date = Apr 15 2019
!Sample_last_update_date = Apr 23 2019
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma_1 hr 10nM E2
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = cell type: Endometrioid adenocarcinoma
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 0.1% DMSO, as a vehicle control, or 10nM E2 (Sigma-Aldrich) for 8 hours
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = total RNA
!Sample_extract_protocol_ch1 = Cells were harvested from 10cm dishes in 600mL RLT Plus (Qiagen) supplemented with 1% beta-mercaptoethanol after an 8 hour induction with 10nM E2 or DMSO.  RNA purification was performed using RNA Clean and Concentrator (Zymo Research) with the optional DNase I treatment.
!Sample_extract_protocol_ch1 = The KAPA Stranded mRNA-seq kit (Kapa Biosystems) was used to create Poly(A) selected libraries from 1mg total RNA.
!Sample_data_processing = Reads were aligned to the human genome using HISAT2
!Sample_data_processing = Sam files were then converted to bam files and sorted via Samtools
!Sample_data_processing = Read counts for each gene were determined from alignments to hg19 UCSC knownGene gene models using featuresCounts from the SubRead package
!Sample_data_processing = Normalization and differential expression analysis were performed using DeSeq2
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: Gene counts in a text file
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = cDNA
!Sample_library_source = transcriptomic
!Sample_library_strategy = RNA-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11417648
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5683065
!Sample_supplementary_file_1 = NONE
!Sample_series_id = GSE129804
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260324
!Sample_title = WTIshikawa_MilliER_E2
!Sample_geo_accession = GSM4260324
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = chip antibody: Millipore ERalpha (06-935)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830732
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544087
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260324/suppl/GSM4260324_WTIshikawa_MilliER_E2.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260324/suppl/GSM4260324_WTIshikawa_MilliER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260325
!Sample_title = ETV4KO1_MilliER_E2
!Sample_geo_accession = GSM4260325
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 1
!Sample_characteristics_ch1 = chip antibody: Millipore ERalpha (06-935)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830738
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544088
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260325/suppl/GSM4260325_ETV4KO1_MilliER_E2.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260325/suppl/GSM4260325_ETV4KO1_MilliER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260326
!Sample_title = ETV4KO2_MilliER_E2
!Sample_geo_accession = GSM4260326
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa ETV4 KO clone 2
!Sample_characteristics_ch1 = chip antibody: Millipore ERalpha (06-935)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830737
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544089
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260326/suppl/GSM4260326_ETV4KO2_MilliER_E2.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260326/suppl/GSM4260326_ETV4KO2_MilliER_E2.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260327
!Sample_title = siNTC_72hr_ER
!Sample_geo_accession = GSM4260327
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2 and 72 hours non-targeting siRNA
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830736
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544090
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260327/suppl/GSM4260327_siNTC_72hr_ER.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260327/suppl/GSM4260327_siNTC_72hr_ER.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260328
!Sample_title = siNTC_96hr_ER
!Sample_geo_accession = GSM4260328
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2 and 96 hours non-targeting siRNA
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830735
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544091
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260328/suppl/GSM4260328_siNTC_96hr_ER.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260328/suppl/GSM4260328_siNTC_96hr_ER.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260329
!Sample_title = siETV4_72hr_ER
!Sample_geo_accession = GSM4260329
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2 and 72 hours ETV4 targeting siRNA
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830734
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544092
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260329/suppl/GSM4260329_siETV4_72hr_ER.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260329/suppl/GSM4260329_siETV4_72hr_ER.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
^SAMPLE = GSM4260330
!Sample_title = siETV4_96hr_ER
!Sample_geo_accession = GSM4260330
!Sample_status = Public on Jan 12 2020
!Sample_submission_date = Jan 12 2020
!Sample_last_update_date = Jan 15 2020
!Sample_type = SRA
!Sample_channel_count = 1
!Sample_source_name_ch1 = Endometrioid adenocarcinoma cell line
!Sample_organism_ch1 = Homo sapiens
!Sample_taxid_ch1 = 9606
!Sample_characteristics_ch1 = cell line: Ishikawa
!Sample_characteristics_ch1 = chip antibody: Santa Cruz ERalpha (HC-20)
!Sample_characteristics_ch1 = treatment: 1 hr 10nM E2 and 96 hours ETV4 targeting siRNA
!Sample_treatment_protocol_ch1 = Inductions involved treating cells with 10nM E2 (Sigma-Aldrich) for 1 hour. siRNAs were transfected either 72 or 96 hours before harvest.
!Sample_growth_protocol_ch1 = Ishikawa cells (Sigma-Aldrich) were grown in full media (RPMI-1640 (Gibco), 10% fetal bovine serum (Gibco), and 1% penicillin-streptomycin (Gibco)).  Five days prior to induction, cells were moved to hormone-depleted media with phenol-red free RPMI-1640(Gibco), 10% charcoal-dextran treated fetal bovine serum (Sigma-Aldrich), and 1% penicillin-streptomycin(Gibco).
!Sample_molecule_ch1 = genomic DNA
!Sample_extract_protocol_ch1 = Cells were crosslinked with 1% formaldehyde for 10 minutes at room temperature. Crosslinking was stopped with 125mM Glycine and cells were washed and scraped in cold PBS. IP was done as described in Reddy et al 2009 using Santa Cruz ERα (HC-20) or Millipore ERα (06-935)
!Sample_extract_protocol_ch1 = TruSeq library construction as described in Reddy et al 2009
!Sample_description = ER ChIP-seq
!Sample_data_processing = Reads were aligned using Bowtie with the parameters: -m 1  -t –best -q -S -l 32 -e 80 -n 2
!Sample_data_processing = Peaks were called using MACS2 with a p-value cutoff of 1e-10 and the mfold parameter constrained between 15 and 100.
!Sample_data_processing = To determine read depth of peaks called, bedtools coverage was used to calculate the counts
!Sample_data_processing = Genome_build: hg19
!Sample_data_processing = Supplementary_files_format_and_content: bedgraph, narrowpeaks
!Sample_platform_id = GPL16791
!Sample_contact_name = Jason,,Gertz
!Sample_contact_email = jay.gertz@hci.utah.edu
!Sample_contact_laboratory = Gertz
!Sample_contact_department = Oncological Sciences
!Sample_contact_institute = University of Utah
!Sample_contact_address = 2000 Circle of Hope
!Sample_contact_city = Salt Lake City
!Sample_contact_state = UT
!Sample_contact_zip/postal_code = 84112
!Sample_contact_country = USA
!Sample_instrument_model = Illumina HiSeq 2500
!Sample_library_selection = ChIP
!Sample_library_source = genomic
!Sample_library_strategy = ChIP-Seq
!Sample_relation = BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13830733
!Sample_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7544093
!Sample_supplementary_file_1 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260330/suppl/GSM4260330_siETV4_96hr_ER.bedGraph.gz
!Sample_supplementary_file_2 = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4260nnn/GSM4260330/suppl/GSM4260330_siETV4_96hr_ER.narrowPeak.gz
!Sample_series_id = GSE129803
!Sample_series_id = GSE129805
!Sample_data_row_count = 0
